• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Direxion Daily S&P Biotech Bull 3X ETF (NY:LABU)

    300.70 +4.39 (+1.48%)
    Official Closing Price Updated: 4:10 PM EDT, Sep 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 213,147
    Open 291.05
    Bid (Size) 300.50 (1,300)
    Ask (Size) 301.70 (300)
    Prev. Close 296.31
    Today's Range 289.32 - 301.50
    52wk Range 71.88 - 341.93
    Shares Outstanding 102,744
    Dividend Yield 1.21%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
    H.C. Wainwright stated that the reported departure of a key U.S. Food and Drug Administration official at the end of April bodes well for uniQure. 
    Via Stocktwits
    Topics Initial Public Offering
    News headline image
    Why Did QURE Stock Almost Halve Pre-Market Today? ↗
    uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130. 
    Via Stocktwits

    Performance

    YTD
    +90.9%
    +90.9%
    1 Month
    +31.9%
    +31.9%
    3 Month
    +65.5%
    +65.5%
    6 Month
    +77.4%
    +77.4%
    1 Year
    +294.6%
    +294.6%

    More News

    Read More
    News headline image
    Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
    Via Stocktwits
    Topics ETFs
    SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval ↗
    Via Stocktwits
    News headline image
    Sector Rotation ↗
    Via Talk Markets
    News headline image
    Can These 5 Assets Skyrocket Your Portfolio? ↗
    Via Talk Markets
    Topics ETFs Stocks
    News headline image
    EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks ↗
    Via Benzinga
    News headline image
    Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win ↗
    Via Talk Markets
    Topics ETFs Stocks
    News headline image
    The 3 Best Leveraged ETFs for April 2024 ↗
    Via InvestorPlace
    Topics ETFs
    News headline image
    5 Best-Performing Leveraged ETFs Of February ↗
    Via Talk Markets
    Topics ETFs Stocks
    News headline image
    Stocks To Watch This Week - Sunday, Feb. 11 ↗
    Via Talk Markets
    Topics ETFs
    News headline image
    Want Diversified Upside in Biotechnology? Check out LABU
    Via MarketBeat
    Topics ETFs Stocks
    News headline image
    The Week Ahead Commentary - Saturday, Feb. 4 ↗
    Via Talk Markets
    News headline image
    J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗
    Via Talk Markets
    News headline image
    3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty ↗
    Via InvestorPlace
    News headline image
    The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)… ↗
    Via Talk Markets
    News headline image
    3 Biotech Stocks to Buy That Are Under Severe Pressure ↗
    Via InvestorPlace
    News headline image
    5 Best Leveraged ETFs of Last Week ↗
    Via Talk Markets
    News headline image
    5 Best-Performing Leveraged ETFs of August ↗
    Via Talk Markets
    News headline image
    The Week In Charts: Figure This Out And You’ll Own The World ↗
    Via Talk Markets
    News headline image
    The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs ↗
    Via Talk Markets
    News headline image
    The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading ↗
    Via Talk Markets
    News headline image
    These Were The Stocks David Green Discussed On His Show This Morning ↗
    Via Benzinga
    News headline image
    The Week In Charts-Volatility: Rabbit Hole Or Holy Grail? ↗
    Via Talk Markets
    News headline image
    A Biotech ETF For Aggressive, Risk-Tolerant Investors ↗
    Via Talk Markets
    Topics Stocks

    Frequently Asked Questions

    Is Direxion Daily S&P Biotech Bull 3X ETF publicly traded?
    Yes, Direxion Daily S&P Biotech Bull 3X ETF is publicly traded.
    What exchange does Direxion Daily S&P Biotech Bull 3X ETF trade on?
    Direxion Daily S&P Biotech Bull 3X ETF trades on the New York Stock Exchange
    What is the ticker symbol for Direxion Daily S&P Biotech Bull 3X ETF?
    The ticker symbol for Direxion Daily S&P Biotech Bull 3X ETF is LABU on the New York Stock Exchange
    What is the current price of Direxion Daily S&P Biotech Bull 3X ETF?
    The current price of Direxion Daily S&P Biotech Bull 3X ETF is 300.70
    When was Direxion Daily S&P Biotech Bull 3X ETF last traded?
    The last trade of Direxion Daily S&P Biotech Bull 3X ETF was at 09/01/26 04:10 PM ET
    What is the market capitalization of Direxion Daily S&P Biotech Bull 3X ETF?
    The market capitalization of Direxion Daily S&P Biotech Bull 3X ETF is 30.90M
    How many shares of Direxion Daily S&P Biotech Bull 3X ETF are outstanding?
    Direxion Daily S&P Biotech Bull 3X ETF has 31M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.